Civic Intelligence

Abzyme Research Foundation

990EZ • Fiscal year 2021 • EIN 27-3438658

Jan 01, 2021 to Dec 31, 2021 • Filed on Nov 09, 2022

Organization ProfileWWW.ENDHIV.COM
67 Irving Place 12th FloorNew York, NY 10003

(347) 967-3734

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

67th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2021 filings • NTEE H • <$500k nonprofits • Source year 2021

Liabilities / Revenue

65th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2021 filings • NTEE H • <$500k nonprofits • Source year 2021

Net Margin

4th percentile

-2094%

Higher net margin than 4% of similar nonprofits.

2021 filings • NTEE H • <$500k nonprofits • Source year 2021

Top Officer Pay

89th percentile

$0

Higher top officer pay than 89% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2021 filings • NTEE H • <$500k nonprofits • Source year 2021

Asset Growth

39th percentile

-0.8%

Faster asset growth than 39% of similar nonprofits.

2021 filings • NTEE H • <$500k nonprofits • Annualized from 2020 to 2021

Revenue Growth

5th percentile

-97%

Faster revenue growth than 5% of similar nonprofits.

2021 filings • NTEE H • <$500k nonprofits • Annualized from 2020 to 2021

Balance Sheet
Liabilities / Assets67th percentile

Assets

Down

$341,865

Down $2,911 (-0.8%) from 2020

Net Assets

Down

$341,865

Down $2,911 (-0.8%) from 2020

Liabilities

Flat

$0

Flat from 2020

Revenue And Expenses
Liabilities / Revenue65th percentileNet Margin4th percentile

Revenue

Down

$139

Down $5,255 (-97%) from 2020

Expenses

Down

$3,050

Down $10,910 (-78%) from 2020

Net Income

Up

-$2,911

Up $5,655 (+66%) from 2020

Historical Trend

Balance Sheet Trend

Asset Growth39th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$400K$300K$200K$100K$0Assets 2017: $385,535Liabilities 2017: $2,215Net Assets 2017: $383,3202017Assets 2018: $351,372Liabilities 2018: $10,750Net Assets 2018: $340,6222018Assets 2019: $353,342Liabilities 2019: $0Net Assets 2019: $353,3422019Assets 2020: $344,776Liabilities 2020: $0Net Assets 2020: $344,7762020Assets 2021: $341,865Liabilities 2021: $0Net Assets 2021: $341,8652021Assets 2022: $336,178Net Assets 2022: $336,1782022Assets 2023: $328,979Net Assets 2023: $328,9792023Assets 2024: $335,298Net Assets 2024: $335,2982024

Highlighted filing

2021

Assets$341,865
Liabilities$0
Net Assets$341,865
Open 2021 Filing

Operations Trend

Revenue Growth5th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500K-$1.0MRevenue 2017: $172,225Expenses 2017: $744,547Net Income 2017: -$572,3222017Revenue 2018: $84,666Expenses 2018: $127,364Net Income 2018: -$42,6982018Revenue 2019: $60,108Expenses 2019: $32,293Net Income 2019: $27,8152019Revenue 2020: $5,394Expenses 2020: $13,960Net Income 2020: -$8,5662020Revenue 2021: $139Expenses 2021: $3,050Net Income 2021: -$2,9112021Revenue 2022: $52Expenses 2022: $5,739Net Income 2022: -$5,6872022Revenue 2023: $23Expenses 2023: $7,223Net Income 2023: -$7,2002023Revenue 2024: $10,001Expenses 2024: $3,682Net Income 2024: $6,3192024

Highlighted filing

2021

Revenue$139
Expenses$3,050
Net Income-$2,911
Open 2021 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2021 to Dec 31, 2021
Signed
Nov 9, 2022
Return Version
2021v4.2
Gross Receipts
$139
Mission and Program Overview

Mission

Advance the development of abzyme technology in the hopes of producing the world's first effective hiv vaccine and improved treatment for over 36 million hiv-positive people worldwide.

Advance the development of abzyme technology in the hopes of producing the world's first effective hiv vaccine and improved treatment for over 36 million hiv positive people worldwide

Program Services

DescriptionGrantsExpenses
THE SUCCESSFUL COMPLETION OF THE PRE-INVESTIGATIONAL NEW DRUG MEETING WITH THE FDA AS WELLAS THE INITIATION OF A SCALE-UP OF THE MANUFACTURING OF THE VACCINE COMPOUND.$0$0
Compensation and Service Providers
Top Officer Pay89th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
ZACHARY BARNETTExecutive DirectorFT$0--
VALERIE KERRDirector-$0--
BETH MILLER SAKSDirector-$0--
TIM VOLKDirector-$0--
ADAM MACLEANChair-$0--
MICHAEL JEFVERTVice-Chair-$0--
NICHOLAS SMITHTreasurer-$0--
AIMEE A DROUINSecretary-$0--
Filing and Contact Details

Filer

Filer Name
Abzyme Research Foundation
EIN
27-3438658
Phone
3479673734
Address
67 IRVING PLACE 12TH FLOOR, NEW YORK, NY 10003

Signing Officer

Name
Zachary Barnett
Title
Executive Director
Phone
3479673734
Signed
2022-11-09
Discuss with paid preparer
Yes

Preparer

Firm
Demasco Sena & Jahelka Llp
Address
1400 OLD COUNTRY RD SUITE 310E, WESTBURY, NY 11590
Preparer
Robert Bjelke
Phone
5165416549
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 4 - Other Investment Income

“Description: interest income. Amount: 8.”

Form 990-ez, Part I, Line 8 - Other Revenue

“Description: miscellaneous income. Amount: 131.”

Form 990-ez, Part I, Line 16 - Other Expenses

“Description: payroll service fees. Amount: 542. Description: office expenses. Amount: 2,383. Total to form 990-ez, line 16: 2,925.”

Form 990-ez, Part II, Line 24 - Other Assets

“Description: investment in covalent bioscience. Beg. Of year amount: 265,658. End of year amount: 265,658.”

Raw XML Appendix182 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990EZ/BooksInCareOfDetail/PhoneNum03479673734
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt067 IRVING PLACE 12TH FL
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0NEW YORK
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd010003
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt079118
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt076207
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt0-2911
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt0125
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0344776
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0341865
IRS990EZ/GrossReceiptsAmt0139
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/InvestmentIncomeAmt08
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0344776
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0341865
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0344776
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0341865
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt050.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt31.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt44.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt51.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt61.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt71.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0ZACHARY BARNETT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1VALERIE KERR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2BETH MILLER SAKS
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3TIM VOLK
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4ADAM MACLEAN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5MICHAEL JEFVERT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm6NICHOLAS SMITH
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm7AIMEE A DROUIN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0EXECUTIVE DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4CHAIR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5VICE-CHAIR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt6TREASURER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt7SECRETARY
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherAssetsTotalDetail/BOYAmt0265658
IRS990EZ/OtherAssetsTotalDetail/EOYAmt0265658
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt02925
IRS990EZ/OtherRevenueTotalAmt0131
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0ADVANCE THE DEVELOPMENT OF ABZYME TECHNOLOGY IN THE HOPES OF PRODUCING THE WORLD'S FIRST EFFECTIVE HIV VACCINE AND IMPROVED TREATMENT FOR OVER 36 MILLION HIV POSITIVE PEOPLE WORLDWIDE
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0THE SUCCESSFUL COMPLETION OF THE PRE-INVESTIGATIONAL NEW DRUG MEETING WITH THE FDA AS WELLAS THE INITIATION OF A SCALE-UP OF THE MANUFACTURING OF THE VACCINE COMPOUND.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt00
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0NY
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt00
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt00
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt03050
IRS990EZ/TotalProgramServiceExpensesAmt00
IRS990EZ/TotalRevenueAmt0139
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.ENDHIV.COM
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt00
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt060084
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt084615
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt0142070
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0286769
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt08
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt04
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt024
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt051
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt0155
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0242
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt05390
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.99920
IRS990ScheduleA/PublicSupportPY170Pct00.99980
IRS990ScheduleA/PublicSupportTotal170Amt0286769
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt060084
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt084615
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt0142070
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0286769
IRS990ScheduleA/TotalSupportAmt0287011
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DESCRIPTION: INTEREST INCOME. AMOUNT: 8.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1DESCRIPTION: MISCELLANEOUS INCOME. AMOUNT: 131.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2DESCRIPTION: PAYROLL SERVICE FEES. AMOUNT: 542. DESCRIPTION: OFFICE EXPENSES. AMOUNT: 2,383. TOTAL TO FORM 990-EZ, LINE 16: 2,925.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3DESCRIPTION: INVESTMENT IN COVALENT BIOSCIENCE. BEG. OF YEAR AMOUNT: 265,658. END OF YEAR AMOUNT: 265,658.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 4 - OTHER INVESTMENT INCOME
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 8 - OTHER REVENUE
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART II, LINE 24 - OTHER ASSETS
TransferPrsnlBnftContractsDecl/DeclarationDesc0THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/AuthenticationAssuranceLevelCd0AAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/IdentityAssuranceLevelCd0IAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/TrustedCustomerCd03
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0ZACHARY BARNETT
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0EXECUTIVE DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum03479673734
ReturnHeader/BusinessOfficerGrp/SignatureDt02022-11-09
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0ABZYME RESEARCH FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0ABZY
ReturnHeader/Filer/EIN0273438658
ReturnHeader/Filer/PhoneNum03479673734
ReturnHeader/Filer/USAddress/AddressLine1Txt067 IRVING PLACE 12TH FLOOR
ReturnHeader/Filer/USAddress/CityNm0NEW YORK
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NY
ReturnHeader/Filer/USAddress/ZIPCd010003
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0113136342
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0DEMASCO SENA & JAHELKA LLP
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt01400 OLD COUNTRY RD SUITE 310E
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0WESTBURY
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NY
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd011590
ReturnHeader/PreparerPersonGrp/PhoneNum05165416549
ReturnHeader/PreparerPersonGrp/PreparationDt02022-11-09
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0ROBERT BJELKE
ReturnHeader/ReturnTs02022-11-15T12:46:09-06:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0ZACHARY
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0BARNETT
ReturnHeader/TaxPeriodBeginDt02021-01-01
ReturnHeader/TaxPeriodEndDt02021-12-31
ReturnHeader/TaxYr02021

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2021 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$341,865
Liabilities
$0
Net assets
$341,865
Revenue
$139
Expenses
$3,050
Net income
-$2,911
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$3.35$3.35$0.10$0.04$0.06
2023Detailed filing. Detailed filing data is available for this year.$3.29$3.29$0.00$0.07$0.07
2022Detailed filing. Detailed filing data is available for this year.$3.36$3.36$0.00$0.06$0.06
2021Detailed filing. Detailed filing data is available for this year.$3.42$0.00$3.42$0.00$0.03$0.03
2020Detailed filing. Detailed filing data is available for this year.$3.45$0.00$3.45$0.05$0.14$0.09
2019Detailed filing. Detailed filing data is available for this year.$3.53$0.00$3.53$0.60$0.32$0.28
2018Detailed filing. Detailed filing data is available for this year.$3.51$0.11$3.41$0.85$1.27$0.43
2017Detailed filing. Detailed filing data is available for this year.$3.86$0.02$3.83$1.72$7.45$5.72